Medical Countermeasure (MCM) Developmental Pipeline
Due: October 28, 2024 The Defense Threat Reduction Agency (DTRA), in its role as the Joint Science and Technology Office (JSTO), seeks to establish an improved drug discovery and development platform that has the capabilities Read More